Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
NCT07123961 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2026-03-16
Summary
Acute respiratory distress syndrome (ARDS) is a serious and potentially life-threatening lung condition that can affect children. Currently, ventilator settings commonly used in treatment are based on approaches developed for adults, and it remains unclear whether these settings are equally effective for children. Because children's bodies respond differently than adults', it is important to determine the most effective ventilator strategies specifically for pediatric patients. This study will compare two different ventilator approaches in children with ARDS to identify which method provides the greatest benefit. The findings will also help inform the design of a larger study in the future.
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
- Ventilator Management
- Lung-protective Ventilation
- Pediatric Acute Respiratory Distress Syndrome (PARDS)
Interventions
- OTHER
-
High Driving Pressure Mechanical Ventilation
A participant who is already invasively mechanically ventilated will be placed on "Pressure Control Ventilation" mode on an Evita V500 (Manufacturer: Dräger, Lübeck, Germany) ventilator if they are not already. The driving pressure will be set to 25 cmH2O (rate of pressure delivery). The Children's Hospital of Philadelphia (CHOP) PICU's standard of care regarding sedation, fluid management, ventilator weaning, and extubation readiness for invasively mechanically ventilated children will be adhered to for the duration of the study. An Enlight 2100 Electrical Impedance Tomography (EIT) Device (Manufacturer: Timpel) strap will be placed across the participant's chest up to four times throughout the study for a few hours to image the aeration in the lungs.
- OTHER
-
Low Driving Pressure Mechanical Ventilation
A participant who is already invasively mechanically ventilated will be placed on "Pressure Control Ventilation" mode on an Evita V500 (Manufacturer: Lübeck, Germany) ventilator if they are not already. The driving pressure will be set to 15 cmH2O (rate of pressure delivery). CHOP PICU's standard of care regarding sedation, fluid management, ventilator weaning, and extubation readiness for invasively mechanically ventilated children will be adhered to for the duration of the study. An Enlight 2100 (EIT) Device (Manufacturer: Timpel) strap will be placed across the participant's chest up to four times throughout the study for a few hours to image the aeration in the lungs.
Sponsors & Collaborators
- collaborator OTHER
-
Children's Hospital of Philadelphia
lead OTHER
Principal Investigators
-
Nadir Yehya, MD, MSCE · Children's Hospital of Philadelphia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Weeks
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-07
- Primary Completion
- 2029-12-31
- Completion
- 2030-06-30
Countries
- United States
Study Locations
More Related Trials
-
Fluid Filled Lung Oxygenation Assistance Trial
NCT03041740 ·Status: COMPLETED ·Phase: PHASE1
-
Pediatric Acute Respiratory Distress Syndrome Ventilation Bundle
NCT03504176 ·Status: COMPLETED
-
Nitric Oxide Administration for Acute Respiratory Distress Syndrome
NCT00240487 ·Status: COMPLETED ·Phase: PHASE3
-
Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT02370095 ·Status: TERMINATED ·Phase: PHASE2
-
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Trial of Steroids in Pediatric Acute Lung Injury/ARDS
NCT01274260 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status Asthmaticus
NCT02539420 ·Status: WITHDRAWN ·Phase: NA
-
BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial
NCT05848115 ·Status: TERMINATED ·Phase: NA
-
Real-time Effort Driven VENTilator Management
NCT03266016 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations
NCT01497691 ·Status: WITHDRAWN ·Phase: NA
-
Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
NCT04064684 ·Status: TERMINATED ·Phase: PHASE2
-
BPAP in Pediatric Asthma Pilot Study
NCT04656587 ·Status: WITHDRAWN ·Phase: NA
-
Outcome of Patients Admitted to Pediatric Intensive Care for Acute Respiratory Failure
NCT06470932 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations
NCT02347462 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Sternal Wall Pressure in Children
NCT00628407 ·Status: COMPLETED
-
NiPPV in the Treatment of Acute Asthma Exacerbations
NCT03219736 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
NCT06897839 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
NCT01403428 ·Status: WITHDRAWN ·Phase: PHASE2
-
NIV NAVA Versus NIV-PS in Pediatric Patients - Pilot Study
NCT01873261 ·Status: UNKNOWN
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure
NCT01873521 ·Status: UNKNOWN ·Phase: PHASE4
-
Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)
NCT00814099 ·Status: COMPLETED ·Phase: NA
-
IPV and Lung Compliance in Invasively Ventilated Children
NCT06836050 ·Status: RECRUITING
-
Apnoeic Oxygenation During Pediatric Tracheal Intubation
NCT06576596 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure
NCT06750536 ·Status: RECRUITING